Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT?

Fig. 3

Comparisons of the receiver operating characteristic curves for distinguishing the tumor resection margin status (R0, R1) and tumor regression grade (TRG) levels (0–2, 3) with tumor size measured by CT and MRI. A Distinguishing R0 and R1 preneoadjuvant therapy (NAT), n = 103; B Distinguishing R0 and R1 after NAT, n = 91; C Distinguishing TRG levels pre-NAT, n = 103; D: Distinguishing TRG levels after NAT, n = 91

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us